Stay updated on AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Sign up to get notified when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.

Latest updates to the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page
- Check6 days agoChange DetectedMinor version update from Revision: v3.4.0 to v3.4.1 with no visible changes to study content or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe label changes from 'Last Update Posted (Estimated)' to 'Last Update Posted'. This is a small metadata update that clarifies when the page was last updated without changing substantive trial information.SummaryDifference0.0%

- Check28 days agoChange DetectedRevision note updated to v3.3.4 and v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedTwo new sites were added to the study locations: Medical Oncology Associates in Spokane, WA, and Mid-Florida Hematology & Oncology Centers in Orange City, FL. The total number of locations increased to 18 (from 16).SummaryDifference0.4%

- Check49 days agoChange DetectedLocations are now presented under a single Locations section with state-specific sites; the HHS Vulnerability Disclosure link was removed and the revision updated to v3.3.3.SummaryDifference0.9%

- Check71 days agoChange DetectedTwo new update timestamps were added to the study record (2025-11-26 and 2025-12-01) and earlier dates were removed; no changes to study design, eligibility, or locations.SummaryDifference0.1%

Stay in the know with updates to AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.